Casma Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Casma Therapeutics's estimated annual revenue is currently $1.8M per year.
- Casma Therapeutics's estimated revenue per employee is $77,500
- Casma Therapeutics's total funding is $108.9M.
Employee Data
- Casma Therapeutics has 23 Employees.
- Casma Therapeutics grew their employee count by -34% last year.
Casma Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | SVP, Drug Discovery | Reveal Email/Phone |
4 | SVP Finance | Reveal Email/Phone |
5 | VP, Head Drug Discovery | Reveal Email/Phone |
6 | VP | Reveal Email/Phone |
7 | SVP People & Culture | Reveal Email/Phone |
8 | SVP Biology | Reveal Email/Phone |
9 | Senior Director, Head Biology | Reveal Email/Phone |
10 | Associate Director, Laboratory Operations & Biomarker Discovery | Reveal Email/Phone |
Casma Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Casma Therapeutics?
We're harnessing the natural cellular process of autophagy to design powerful new medicines for a broad range of diseases.
keywords:N/A
$108.9M
Total Funding
23
Number of Employees
$1.8M
Revenue (est)
-34%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Casma Therapeutics News
CAMBRIDGE, Mass., April 07, 2022 (GLOBE NEWSWIRE) -- Casma Therapeutics, Inc., a biotechnology company engaging the autophagy system to...
AbbVie; Accelero Biostructures; Amgen; Amphista Therapeutics ... Caraway Therapeutics; Casma Therapeutics; Celeris Therapeutics...
Casma Therapeutics — a biotechnology company harnessing autophagy and the lysosome to design powerful new medicines — announced it has raised $50 million in Series B funding Casma Therapeutics — a biotechnology company harnessing autophagy and the lysosome to design powerful new medicines — ann ...
Fierce 15 winner Casma Therapeutics has bagged $50 million as it looks to kick on with its early work in muscular dystrophy. Sponsored by Agilent Technologies How would you like to win free bench space at Lab Central for one scientist for an entire year? Enter the Agilent LabCentral Golden Tic ...
Casma Therapeutics, Inc., a Cambridge, Mass.-based biotechnology company, completed a $50m Series B financing. The round, led by The Column Group (TCG), adds new investors Eventide Asset Management, LLC and Schroder Adveq, as well as other undisclosed institutional investors. Existing investor ...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.7M | 23 | -4% | $8M |
#2 | $2.9M | 23 | 0% | N/A |
#3 | $2.3M | 23 | -38% | N/A |
#4 | $2.3M | 23 | -23% | N/A |
#5 | $1.6M | 23 | -8% | N/A |